Reimbursement for Breakthrough Devices Still Lags—Need for TCET: An Interview with Josh Makower


Episode Artwork
1.0x
0% played 00:00 00:00
Sep 18 2023 56 mins  

This discussion with Stanford Biodesign director and co-founder Josh Makower highlights a recent Stanford report that found the median time for initial coverage of breakthrough devices was nearly six years. Here we discuss how this data, much like information from previous Stanford reports, can help drive change in the current debate over TCET (transitional coverage for emerging technologies) to help speed this process.